« Previous
Next »
Psychiatry Research
Volume 170, Issue 2
, Pages 273-275
, 30 December 2009
Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression
References
- . Antidepressant effects of right versus left unilateral ECT and the lateralization theory of ECT action. American Journal of Psychiatry. 1989;146:1190–1192
- . The GDNF family: signaling, biological functions and therapeutic value. Nature Reviews Neuroscience. 2002;3:383–394
- . Diagnostic and Statistical Manual of Mental Disorders. 4th Ed.. Washington, DC.: Author; 1994;
- . Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. The Journal of ECT. 2002;18:138–143
- . Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. The International Journal of Neuropsychopharmacology. 2003;6:225–231
- . Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. European Neuropsychopharmacology. 2006;16:620–624
- . Neuropsychiatric applications of transcranial magnetic stimulation: analysis. The International Journal of Neuropsychopharmacology. 2002;5:73–103
- . Novel targets for valproic acid: upregulation of melatonin receptors and neurotrophic factors in C6 glioma cells. Journal of Neurochemistry. 2005;95:1227–1236
- . Molecular and cellular actions of chronic electroconvulsive seizures. The Journal of ECT. 1998;14:181–193
- . Definition and epidemiology of treatment-resistant depression. The Psychiatric Clinics of North America. 1996;19:179–200
- . Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. European Journal of Neuroscience. 2001;14:1153–1163
- . Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse. Experimental Neurology. 1999;158:504–528
- . Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience. 2001;24:677–736
- . Increased neurogenesis in a model of electroconvulsive therapy. Biological Psychiatry. 2000;47:1043–1049
- . Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. The Journal of Clinical Psychiatry. 2007;68:512–517
- . MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocyte. Journal of Molecular Neuroscience. 2004;24:207–216
- . Role or GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron. 2000;26:247–257
- . Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation. Journal of Psychiatric Research. 2006;40:153–159
- . Development and persistence of kindling epilepsy are impaired in mice lacking glial cell line-derived neurotrophic factor family receptor alpha 2. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:12312–12317
- . Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study. Progress in Neuro-Psychopharmacology&Biological Psychiatry. 2008;32:11850-1190
- . Altered expression of neurotrophic factors in patients with major depression. Journal of Psychiatric Research. 2008;42:1145–1153
- . Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37:1553–1561
- . Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Research. 1996;709:122–130
- . Reductions on neuronal and glial density and characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry. 2001;49:741–752
- . Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neuroscience Letters. 2006;407:146–150
- . Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. Journal of Psychiatry & Neuroscience. 2006;31:32–37
- . Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. The International Journal of Neuropsychopharmacollogy. 2006;9:607–612
- . When at first you don't succeed: sequential strategies for antidepressant nonresponders. The Journal of Clinical Psychiatry. 1997;58:23–29
- . Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience. 1999;89:157–166
- . Cross-national epidemiology of major depression and bipolar disorder. JAMA: The Journal of the American Medical Association. 1996;276:293–299
- . Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2008;32:886–890
PII: S0165-1781(09)00019-5
doi: 10.1016/j.psychres.2009.01.011
© 2009 Elsevier B.V. All rights reserved.
« Previous
Next »
Psychiatry Research
Volume 170, Issue 2
, Pages 273-275
, 30 December 2009
